Perspective Therapeutics, Inc. Share Price
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
19:16:01 11/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.8360 USD | +6.31% |
|
-3.59% | -69.49% |
| Market Cap | 94.96M 85.59M 79.08M 71.49M 135M 8.91B 139M 948M 378M 4.77B 356M 349M 15.18B | P/E 2026 * |
-0.77x | P/E 2027 * | -0.75x |
|---|---|---|---|---|---|
| Enterprise Value | -71.59M -64.52M -59.61M -53.89M -102M -6.71B -104M -714M -285M -3.6B -269M -263M -11.44B | EV / Sales 2026 * |
-344x | EV / Sales 2027 * | -447x |
| Free-Float |
91.76% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| CATX | Delayed | |
CBOE
| CATX | Real-time | |
|
Tradegate
| AAJ0 | Real-time | |
|
Boerse Muenchen
| AAJ0 | Real-time | |
|
Deutsche Boerse AG
| AAJ0 | Delayed | |
|
Börse Stuttgart
| AAJ0 | Delayed |
Last Transcript: Perspective Therapeutics, Inc.
| 1 day | +4.53% | ||
| 1 week | -6.03% | ||
| Current month | -28.90% | ||
| 1 month | -67.55% | ||
| 3 months | -74.29% | ||
| 6 months | -78.93% | ||
| Current year | -70.27% |
| 1 week | 0.78 |  | 0.91 |
| 1 month | 0.78 | | 2.67 |
| Current year | 0.78 | | 6.16 |
| 1 year | 0.78 | | 6.16 |
| 3 years | 0.78 | | 19.05 |
| 5 years | 0.78 | | 19.05 |
| 10 years | 0.78 | | 28.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Johan Spoor
CEO | Chief Executive Officer | 54 | 04/02/2023 |
Joel D. Sendek
DFI | Director of Finance/CFO | 59 | 03/09/2025 |
Shane Cobb
COO | Chief Operating Officer | - | 31/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Johan Spoor
BRD | Director/Board Member | 54 | 04/02/2023 |
Lori Woods
CHM | Chairman | 63 | 02/02/2023 |
| Director/Board Member | 60 | 04/02/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/09/26 | Sell | Company | -167,149 | 0.1464% | ||
| 02/09/26 | Sell | Company | -42,129 | 0.0369% | ||
| 01/09/26 | Sell | Company | -35,769 | 0.0313% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.78% | -6.03% | -63.17% | -65.03% | 94.96M | |
| -1.06% | +9.92% | +59.12% | +68.61% | 68.32B | |
| +1.30% | +7.41% | +14.79% | +90.26% | 60.26B | |
| +0.39% | +0.30% | +20.04% | +97.74% | 55.86B | |
| -0.64% | +11.41% | +22.48% | +111.66% | 48.43B | |
| +0.77% | +5.23% | +27.03% | +43.33% | 45.34B | |
| -5.45% | -8.99% | +183.63% | +824.94% | 41.76B | |
| +1.97% | +9.00% | +25.20% | +50.98% | 34.5B | |
| -0.56% | -0.48% | +85.57% | +57.71% | 33.8B | |
| -1.49% | +13.52% | +43.09% | +0.06% | 25.96B | |
| Average | -0.06% | +2.80% | +41.78% | +128.03% | 41B | |
| Weighted average by Cap. | -0.50% | +4.03% | +50.46% | +147.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 208K 187K 173K 157K 296K 19.51M 304K 2.08M 827K 10.45M 781K 764K 33.25M | 304K 274K 253K 229K 433K 28.54M 444K 3.04M 1.21M 15.29M 1.14M 1.12M 48.65M |
| Net income | -122M -110M -101M -91.49M -173M -11.4B -177M -1.21B -483M -6.1B -456M -446M -19.43B | -138M -125M -115M -104M -197M -12.98B -202M -1.38B -551M -6.95B -520M -509M -22.13B |
| Net Debt | -167M -150M -139M -125M -237M -15.62B -243M -1.66B -662M -8.37B -625M -612M -26.62B | -231M -208M -192M -174M -329M -21.65B -337M -2.3B -918M -11.6B -866M -848M -36.9B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/11/26 | US$0.8396 | +6.77% | 2,719,657 |
| 10/11/26 | US$0.7864 | -8.09% | 8,468,712 |
| 09/11/26 | US$0.8556 | +1.86% | 2,936,155 |
| 06/11/26 | US$0.8400 | +6.54% | 3,135,348 |
| 05/11/26 | US$0.7884 | -9.40% | 3,841,191 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CATX Stock
Select your edition
All financial news and data tailored to specific country editions
